SMAD2 and neoplasm: The finding that rhPRG4 suppresses TGFβ-induced invasive growth without affecting phosphorylation and the transcriptional activity of the receptor-regulated Smads (R-Smad, e.g. Smad2) raises the possibility that the ability of TGFβ to suppress tumor growth might be intact, which can be the subject of future investigations.